Your browser doesn't support javascript.
loading
Prostate-specific antigen kinetics and biochemical control following stereotactic body radiation therapy, high dose rate brachytherapy, and low dose rate brachytherapy: A multi-institutional analysis of 3502 patients.
Levin-Epstein, Rebecca; Cook, Ryan R; Wong, J Karen; Stock, Richard G; Jeffrey Demanes, D; Collins, Sean P; Aghdam, Nima; Suy, Simeng; Mantz, Constantine; Katz, Alan J; Nickols, Nicholas G; Miszczyk, Leszek; Napieralska, Aleksandra; Namysl-Kaletka, Agnieszka; Prionas, Nicholas D; Bagshaw, Hilary; Buyyounouski, Mark K; Cao, Minsong; Mahal, Brandon A; Shabsovich, David; Dang, Audrey; Yuan, Ye; Rettig, Matthew B; Chang, Albert J; Jackson, William C; Spratt, Daniel E; Lehrer, Eric J; Zaorsky, Nicholas G; Kupelian, Patrick A; Steinberg, Michael L; Horwitz, Eric M; Jiang, Naomi Y; Kishan, Amar U.
Afiliação
  • Levin-Epstein R; Department of Radiation Oncology, University of California Los Angeles, Los Angeles, United States.
  • Cook RR; Department of Radiation Oncology, University of California Los Angeles, Los Angeles, United States.
  • Wong JK; Department of Radiation Oncology, Fox Chase Cancer Center, Philadelphia, United States.
  • Stock RG; Department of Radiation Oncology, Icahn School of Medicine at Mount Sinai, New York, United States.
  • Jeffrey Demanes D; Department of Radiation Oncology, University of California Los Angeles, Los Angeles, United States; California Endocurietherapy Cancer Center, Oakland, United States.
  • Collins SP; Department of Radiation Medicine, Georgetown University Hospital, Washington, United States.
  • Aghdam N; Department of Radiation Medicine, Georgetown University Hospital, Washington, United States.
  • Suy S; Department of Radiation Medicine, Georgetown University Hospital, Washington, United States.
  • Mantz C; 21(st) Century Oncology, Inc., Fort Myers, United States.
  • Katz AJ; FROS Radiation Oncology and Cyberknife Center, Flushing, United States.
  • Nickols NG; Department of Radiation Oncology, University of California Los Angeles, Los Angeles, United States; Department of Radiation Oncology, West Los Angeles Veterans Health Administration, Los Angeles, United States.
  • Miszczyk L; Maria Sklodowska-Curie Memorial Cancer Center and Institute of Oncology Gliwice Branch, Gliwice, Poland.
  • Napieralska A; Maria Sklodowska-Curie Memorial Cancer Center and Institute of Oncology Gliwice Branch, Gliwice, Poland.
  • Namysl-Kaletka A; Maria Sklodowska-Curie Memorial Cancer Center and Institute of Oncology Gliwice Branch, Gliwice, Poland.
  • Prionas ND; Department of Radiation Oncology, Stanford University Medical Center, Stanford, United States.
  • Bagshaw H; Department of Radiation Oncology, Stanford University Medical Center, Stanford, United States.
  • Buyyounouski MK; Department of Radiation Oncology, Stanford University Medical Center, Stanford, United States.
  • Cao M; Department of Radiation Oncology, University of California Los Angeles, Los Angeles, United States.
  • Mahal BA; Dana-Farber Cancer Institute and Brigham and Women's Hospital, Boston, United States.
  • Shabsovich D; David Geffen School of Medicine, University of California, Los Angeles, United States.
  • Dang A; Department of Radiation Oncology, Tulane Medical Center, New Orleans, United States.
  • Yuan Y; Department of Radiation Oncology, University of California Los Angeles, Los Angeles, United States.
  • Rettig MB; Department of Medical Oncology, University of California Los Angeles, Los Angeles, United States; Department of Medical Oncology, West Los Angeles Veterans Health Administration, Los Angeles, United States.
  • Chang AJ; Department of Radiation Oncology, University of California Los Angeles, Los Angeles, United States.
  • Jackson WC; Department of Radiation Oncology, University of Michigan, Ann Arbor, United States.
  • Spratt DE; Department of Radiation Oncology, University of Michigan, Ann Arbor, United States.
  • Lehrer EJ; Department of Radiation Oncology, Icahn School of Medicine at Mount Sinai, New York, United States.
  • Zaorsky NG; Department of Radiation Oncology, Penn State Cancer Institute, Hershey, United States.
  • Kupelian PA; Department of Radiation Oncology, University of California Los Angeles, Los Angeles, United States.
  • Steinberg ML; Department of Radiation Oncology, University of California Los Angeles, Los Angeles, United States.
  • Horwitz EM; Department of Radiation Oncology, Fox Chase Cancer Center, Philadelphia, United States.
  • Jiang NY; Department of Radiation Oncology, University of California Los Angeles, Los Angeles, United States.
  • Kishan AU; Department of Radiation Oncology, University of California Los Angeles, Los Angeles, United States. Electronic address: aukishan@mednet.ucla.edu.
Radiother Oncol ; 151: 26-32, 2020 10.
Article em En | MEDLINE | ID: mdl-32663537
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Neoplasias da Próstata / Braquiterapia / Radiocirurgia Tipo de estudo: Observational_studies / Prognostic_studies / Risk_factors_studies Limite: Humans / Male Idioma: En Ano de publicação: 2020 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Neoplasias da Próstata / Braquiterapia / Radiocirurgia Tipo de estudo: Observational_studies / Prognostic_studies / Risk_factors_studies Limite: Humans / Male Idioma: En Ano de publicação: 2020 Tipo de documento: Article